Citigroup
INVA icon

Citigroup’s Innoviva INVA Stock Holding History

Citigroup’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,200
Closed -$110K – 7739
2018
Q3 		$110K Buy
7,200
+7,000
+3,500% +$101K ﹤0.01% 5805
2018
Q2 		$3K Sell
200
-600
-75% -$8.99K ﹤0.01% 7426
2018
Q1 		$13K Sell
800
-2,300
-74% -$35.5K ﹤0.01% 6939
2017
Q4 		$44K Buy
3,100
+2,800
+933% +$37.3K ﹤0.01% 6263
2017
Q3 		$4K Buy
300
+100
+50% +$1.32K ﹤0.01% 6901
2017
Q2 		$3K Sell
200
-1,700
-89% -$21.3K ﹤0.01% 6884
2017
Q1 		$26K Sell
1,900
-400
-17% -$4.71K ﹤0.01% 6101
2016
Q4 		$25K Buy
2,300
+200
+10% +$2.1K ﹤0.01% 6443
2016
Q3 		$23K Sell
2,100
-400
-16% -$4.67K ﹤0.01% 6129
2016
Q2 		$26K Sell
2,500
-2,700
-52% -$31.9K ﹤0.01% 6002
2016
Q1 		$65K Buy
5,200
+5,000
+2,500% +$54.9K ﹤0.01% 5958
2015
Q4 		$2K Sell
200
-3,300
-94% -$30.3K ﹤0.01% 7263
2015
Q3 		$25K Sell
3,500
-3,200
-48% -$43.5K ﹤0.01% 5874
2015
Q2 		$121K Buy
+6,700
New +$115K ﹤0.01% 4848

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's INVA Position: Q1 2026 in Review

Citigroup reduced its Innoviva (INVA) stake by 41% in Q1 2026, selling an estimated $469K and leaving 31,732 shares worth $739K. The position accounts for ﹤0.01% of the portfolio, ranked #3309.

Citigroup first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.83M in Q4 2018. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Citigroup held 31,732 shares of Innoviva worth $739K as of Q1 2026.
  • Citigroup sold 21,780 Innoviva shares in Q1 2026, an estimated $469K.
  • Innoviva made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3309 holding.
  • Citigroup first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Innoviva position peaked at $2.83M in Q4 2018.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.